Cost-effectiveness data use in promotions to be discussed at FDA March pharmacoeconomics meeting.

Executive Summary

COST-EFFECTIVENESS DATA IN PROMOTIONS: FDA MARCH 23-24 CONFERENCE will feature a panel on cost-effectiveness data as a marketing tool as part of a full two-day agenda. Battelle Center for Public Health Research & Evaluation Director Bryan Luce, PhD, and FDA Division of Drug Marketing, Advertising and Communications Director Lucy Rose will appear on the panel, "Comparing Treatment: Safety, Effectiveness and Cost-Effectiveness." The FDA-sponsored meeting is to be held at the National Institutes of Health's Masur Auditorium ("The Pink Sheet" Jan. 23, In Brief).